Showing results (31-40 of 87) with videos related to
Sort By:
Pageof 9
Journal of Applied Microbiology|April 15, 2018
Antibacterial efficacy and mechanisms of action of low power atmospheric pressure cold plasma: membrane permeability, biofilm penetration and antimicrobial sensitizationP Brun, G Bernabè, C Marchiori, et al.Journal of Clinical Gastroenterology|January 1, 1988
Ursodeoxycholic acid for chronic liver diseasesM Podda, C Ghezzi, P M Battezzati, et al.Hepatology (Baltimore, Md.)|December 1, 1991
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationA Crosignani, M Podda, P M Battezzati, et al.Surgical Endoscopy|April 5, 2001
Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approachM Montorsi, R Santambrogio, P Bianchi, et al.Journal of Ultrasound|February 12, 2013
Intraoperative ultrasound patterns predict recurrences after surgical treatments for hepatocellular carcinoma()R Santambrogio, M Costa, D Strada, et al.Hepato-Gastroenterology|March 28, 2001
Laparoscopic radiofrequency of hepatocellular carcinoma (HCC) in liver cirrhosisM Montorsi, R Santambrogio, P Bianchi, et al.Journal of Hepatology|May 1, 1995
Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulationsG Torgano, M Vecchi, M Podda, et al.Digestive Diseases and Sciences|April 1, 1996
Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response studyA Crosignani, P M Battezzati, K D Setchell, et al.Alimentary Pharmacology & Therapeutics|September 13, 2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patientsP M Battezzati, M Zuin, A Crosignani, et al.Arzneimittel-Forschung|October 29, 2000
Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulationsM Zuin, M Podda, C Selmi, et al.Pageof 9